Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Lifted by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 129.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 689,500 shares of the pharmacy operator’s stock after acquiring an additional 388,742 shares during the period. Gamco Investors INC. ET AL’s holdings in Walgreens Boots Alliance were worth $15,334,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Candriam Luxembourg S.C.A. raised its holdings in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after buying an additional 310 shares in the last quarter. Signet Financial Management LLC lifted its position in shares of Walgreens Boots Alliance by 1.0% during the 1st quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator’s stock worth $1,588,000 after buying an additional 334 shares during the period. Pinnacle Financial Partners Inc lifted its position in shares of Walgreens Boots Alliance by 3.5% during the 2nd quarter. Pinnacle Financial Partners Inc now owns 9,940 shares of the pharmacy operator’s stock worth $283,000 after buying an additional 336 shares during the period. Vantage Consulting Group Inc lifted its position in shares of Walgreens Boots Alliance by 1.7% during the 2nd quarter. Vantage Consulting Group Inc now owns 20,759 shares of the pharmacy operator’s stock worth $591,000 after buying an additional 344 shares during the period. Finally, Syntax Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 1.7% during the 2nd quarter. Syntax Advisors LLC now owns 20,759 shares of the pharmacy operator’s stock worth $591,000 after buying an additional 344 shares during the period. Institutional investors and hedge funds own 57.92% of the company’s stock.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $22.16 on Tuesday. The business’s 50-day moving average price is $23.68 and its two-hundred day moving average price is $23.81. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.27. The firm has a market cap of $19.11 billion, a PE ratio of 33.58, a P/E/G ratio of 1.38 and a beta of 0.74. Walgreens Boots Alliance, Inc. has a 1-year low of $19.68 and a 1-year high of $37.13.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. The firm had revenue of $36.70 billion for the quarter, compared to analyst estimates of $34.95 billion. Walgreens Boots Alliance had a return on equity of 10.48% and a net margin of 0.40%. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.16 earnings per share. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.28 earnings per share for the current year.

Walgreens Boots Alliance Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.51%. The ex-dividend date of this dividend is Friday, February 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 290.91%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on WBA. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. Royal Bank of Canada dropped their price target on Walgreens Boots Alliance from $29.00 to $26.00 and set a “sector perform” rating for the company in a report on Friday, October 13th. HSBC began coverage on Walgreens Boots Alliance in a report on Friday, December 22nd. They set a “hold” rating and a $27.00 price target for the company. Evercore ISI dropped their price target on Walgreens Boots Alliance from $26.00 to $21.00 in a report on Wednesday, October 11th. Finally, Truist Financial dropped their price target on Walgreens Boots Alliance from $30.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $28.25.

Get Our Latest Research Report on Walgreens Boots Alliance

Insiders Place Their Bets

In other Walgreens Boots Alliance news, CEO Timothy C. Wentworth purchased 10,000 shares of the stock in a transaction on Friday, January 5th. The shares were purchased at an average price of $24.22 per share, with a total value of $242,200.00. Following the completion of the transaction, the chief executive officer now directly owns 585,122 shares in the company, valued at $14,171,654.84. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Valerie B. Jarrett bought 4,456 shares of the firm’s stock in a transaction dated Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Timothy C. Wentworth bought 10,000 shares of the firm’s stock in a transaction dated Friday, January 5th. The stock was purchased at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the transaction, the chief executive officer now directly owns 585,122 shares of the company’s stock, valued at approximately $14,171,654.84. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.